- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharma
Actavis plc+ Add to Watchlist
ACT:US297.62 USD 7.14 2.34%
As of 20:04:06 ET on 03/31/2015.
Company Profile for Actavis plc (ACT)
Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.
Key Executives for Actavis plc (ACT)
|Paul M BisaroChairman||Brenton L Saunders "Brent"President/CEO|
|Maria Teresa Hilado "Tessa"Chief Financial Officer||Robert A Stewart "Bob"Chief Operating Officer|
|Karen LingChief Human Resources Officer||James C D'AreccaChief Accounting Officer|
|Charles M MayrChief Communications Ofcr:Global||A Robert Bailey "Bob"Chief Legal Officer/Secretary|
|William Meury "Bill"Exec VP:Commercial||David A BuchenExec VP:Commercial|
|Lisa M DefrancescoVP:Global Investor Relations|